![Peter Brandt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Brandt
Directeur/Membre du Conseil chez
IN8BIO, INC.
Fortune : 139 153 $ au 30/06/2026
Profil
Peter C.
Brandt is currently an Independent Director at IN8bio, Inc. since 2019.
Formerly, served as President, Chief Executive Officer & Director at Noven Pharmaceuticals, Inc. from 2008 to 2009.
Served as Chairman, President & Chief Executive Officer at Epocrates LLC from 2012 to 2013.
Held the position of President & Chief Executive Officer at Epocrates, Inc. (Research).
Was an Independent Director at Auxilium Pharmaceuticals LLC from 2011 to 2015 and at Rexahn Pharmaceuticals, Inc. from 2010 to 2015.
Worked at Pfizer Inc. as President-Pharmaceutical Operations from 1981 to 2007.
Held the role of Senior VP-Finance, Planning & Business Development at Pfizer Health Solutions, Inc. in 2005.
Education includes undergraduate studies at the University of Connecticut and an MBA from Columbia Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IN8BIO, INC. 1 % | 09/05/2026 | 98 690 ( 1 % ) | 139 153 $ | 30/06/2026 |
Postes actifs de Peter Brandt
| Sociétés | Poste | Début |
|---|---|---|
| IN8BIO, INC. | Directeur/Membre du Conseil | 01/07/2019 |
Anciens postes connus de Peter Brandt
| Sociétés | Poste | Fin |
|---|---|---|
| AUXILIUM PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 29/01/2015 |
Epocrates LLC
 Epocrates LLC Medical SpecialtiesHealth Technology Provides clinical tools and solutions | Directeur Général | 01/01/2013 |
Noven Pharmaceuticals, Inc.
 Noven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, manufacture, marketing and sale of transdermal pharmaceutical products | Directeur Général | 14/07/2009 |
| PFIZER INC. | Corporate Officer/Principal | 01/05/2007 |
Pfizer Health Solutions, Inc.
 Pfizer Health Solutions, Inc. Medical DistributorsDistribution Services Develops and implements health technology solutions | Directeur Financier/CFO | 01/12/2005 |
Formation de Peter Brandt
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, manufacture, marketing and sale of transdermal pharmaceutical products | Commercial Services |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Auxilium Pharmaceuticals LLC
 Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Epocrates LLC
Epocrates LLC Medical SpecialtiesHealth Technology Provides clinical tools and solutions | Health Technology |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Pfizer Health Solutions, Inc.
Pfizer Health Solutions, Inc. Medical DistributorsDistribution Services Develops and implements health technology solutions | Distribution Services |
Epocrates, Inc. (Research)
 Epocrates, Inc. (Research) Investment ManagersFinance Operates as an investment research firm | Finance |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IN8bio, Inc.
 IN8bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on delivering a novel off-the-shelf product for the treatment of cancer | Health Technology |
Choisissez Zonebourse 
